Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.6M Sell
4,127,412
-8,024,068
-66% -$115M 6.9% 3
2026
Q1
$197M Buy
12,151,480
+2,878,052
+31% +$34M 16.34% 1
2025
Q4
$34.5M Hold
9,273,428
2.23% 16
2025
Q3
$20.2M Buy
9,273,428
+2,516,672
+37% +$4M 1.63% 21
2025
Q2
$8.58M Hold
6,756,756
0.88% 23
2025
Q1
$9.26M Hold
6,756,756
1.23% 17
2024
Q4
$17M Hold
6,756,756
1.9% 11
2024
Q3
$18.4M Hold
6,756,756
1.53% 13
2024
Q2
$15.9M Buy
+6,756,756
New +$14.6M 1.47% 15

Other funds holding ERAS

Vivo Capital's ERAS Position: Q2 2026 in Review

Vivo Capital reduced its Erasca (ERAS) stake by 66% in Q2 2026, selling an estimated $115M and leaving 4,127,412 shares worth $75.6M. The position accounts for 6.9% of the portfolio, ranked #3.

Vivo Capital first reported a position in ERAS in Q2 2024 and has held it in 9 quarters since. The position peaked at $197M in Q1 2026. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Vivo Capital held 4,127,412 shares of Erasca worth $75.6M as of Q2 2026.
  • Vivo Capital sold 8,024,068 Erasca shares in Q2 2026, an estimated $115M.
  • Erasca made up 6.9% of Vivo Capital's portfolio in Q2 2026, its #3 holding.
  • Vivo Capital first reported a position in Erasca in Q2 2024 and has held it in 9 quarters since.
  • Vivo Capital's Erasca position peaked at $197M in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Vivo Capital's 13F filing for Q2 2026, filed 14 Aug 2026.